5.0May 1, 2024Formulation scientistFormer employeeAndover, MARecommendCEO approvalBusiness outlookProsthis is a high payConsthis company no longer existsShow more
5.0Jul 29, 2023Senior managerFormer employeeRecommendCEO approvalBusiness outlookProsGreat company, innovative cancer immunotherapy platformConsSuffered the fate of many biotech startups in a tough investment envirnomentShow moreHelpfulShare
4.0Jan 4, 2025ScientistFormer employeeRecommendCEO approvalBusiness outlookProsCollaboration between different departments for common goalConsLeadership didn’t always agree with each otherShow moreHelpfulShare